Enlivex Ltd. - Ordinary Shares (ENLV) SEC filings
ENLV SEC filings moved a median of -0.52% by the close. ENLV SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ENLV overview →
100 measured ENLV SEC filing events.
Where these ENLV SEC filings landedvs 100 measured ENLV SEC filing reactions
| Middle 50% of ENLV SEC filing reactions | -4.66% to +2.64% |
|---|---|
| Median reaction (to close) | -0.52% |
| Measured reactions | 100 |
Point-in-time · zero look-ahead
Half of the 100 ENLV SEC filing events with a measured close landed between -4.66% and +2.64%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 6-K/A Enlivex Ltd. For: Oct 02 | SEC filing · Form 6-K | -0.03% | -9.50% | |
| Form 6-K/A Enlivex Ltd. For: Sep 30 | SEC filing · Form 6-K | -4.15% | -14.09% | |
| Form 6-K Enlivex Ltd. For: Sep 29 | SEC filing · Form 6-K | -1.12% | +4.53% | |
| Form 6-K Enlivex Ltd. For: Jun 30 | SEC filing · Form 6-K | -8.62% | -14.33% | |
| Form 6-K Enlivex Ltd. For: Sep 22 | SEC filing · Form 6-K | -4.26% | -6.32% | |
| Form EFFECT Enlivex Ltd. | SEC filing · Form EFFECT | -4.68% | -7.60% | |
| Form 6-K Enlivex Ltd. For: Aug 11 | SEC filing · Form 6-K | -1.00% | -8.00% | |
| Form F-3 Enlivex Ltd. | SEC filing · Form F-3 | +0.00% | +5.05% | |
| Form 6-K Enlivex Ltd. For: Jul 30 | SEC filing · Form 6-K | -2.67% | -13.33% | |
| Form 6-K Enlivex Ltd. For: Jul 29 | SEC filing · Form 6-K | -5.68% | -1.75% | |
| Form 6-K Enlivex Ltd. For: Jul 28 | SEC filing · Form 6-K | -2.91% | -31.29% | |
| Form 6-K Enlivex Ltd. For: Jul 20 | SEC filing · Form 6-K | +0.21% | -1.49% | |
| Form 6-K Enlivex Ltd. For: Jul 13 | SEC filing · Form 6-K | -9.81% | -9.13% | |
| Form 6-K Enlivex Ltd. For: Jul 07 | SEC filing · Form 6-K | +4.53% | +0.82% | |
| Form 6-K Enlivex Ltd. For: Jun 24 | SEC filing · Form 6-K | -2.60% | -0.95% | |
| Form 6-K Enlivex Ltd. For: Jun 22 | SEC filing · Form 6-K | +0.00% | -1.16% | |
| Form 6-K Enlivex Ltd. For: May 28 | SEC filing · Form 6-K | -2.32% | -6.78% | |
| Form 6-K Enlivex Ltd. For: May 27 | SEC filing · Form 6-K | +9.48% | +4.41% | |
| Form 6-K Enlivex Ltd. For: May 18 | SEC filing · Form 6-K | +1.29% | -4.48% | |
| Form 6-K Enlivex Ltd. For: May 15 | SEC filing · Form 6-K | +1.29% | -4.48% | |
| Form EFFECT Enlivex Ltd. | SEC filing · Form EFFECT | +2.38% | -2.86% | |
| Form 6-K Enlivex Ltd. For: Apr 21 | SEC filing · Form 6-K | -5.53% | -6.54% | |
| Form F-3 Enlivex Ltd. | SEC filing · Form F-3 | -0.59% | +0.18% | |
| Form 6-K Enlivex Ltd. For: Apr 08 | SEC filing · Form 6-K | +2.84% | +8.37% | |
| Form 6-K Enlivex Ltd. For: Mar 26 | SEC filing · Form 6-K | -5.21% | -5.22% | |
| Form 20-F Enlivex Ltd. For: Dec 31 | SEC filing · Form 20-F | +0.01% | -7.69% | |
| Form 6-K Enlivex Ltd. For: Mar 25 | SEC filing · Form 6-K | +0.01% | -7.69% | |
| Form 6-K Enlivex Ltd. For: Mar 24 | SEC filing · Form 6-K | -1.83% | +0.92% | |
| Form 6-K Enlivex Ltd. For: Mar 23 | SEC filing · Form 6-K | -0.94% | +3.74% | |
| Form S-8 Enlivex Ltd. | SEC filing · Form S-8 | +0.96% | +3.85% | |
| Form 6-K Enlivex Ltd. For: Feb 23 | SEC filing · Form 6-K | -1.72% | +1.96% | |
| Form 6-K Enlivex Therapeutics For: Feb 10 | SEC filing · Form 6-K | -2.59% | -0.86% | |
| Form 6-K Enlivex Therapeutics For: Feb 05 | SEC filing · Form 6-K | -2.29% | +6.42% | |
| Form 6-K Enlivex Therapeutics For: Jan 26 | SEC filing · Form 6-K | -3.67% | +7.34% | |
| Form 6-K Enlivex Therapeutics For: Jan 23 | SEC filing · Form 6-K | -1.83% | -0.92% | |
| Form 6-K Enlivex Therapeutics For: Jan 07 | SEC filing · Form 6-K | -3.09% | -3.28% | |
| Form EFFECT Enlivex Therapeutics | SEC filing · Form EFFECT | -3.25% | -3.83% | |
| Form F-3 Enlivex Therapeutics | SEC filing · Form F-3 | -0.85% | -5.97% | |
| Form 6-K Enlivex Therapeutics For: Dec 18 | SEC filing · Form 6-K | +2.24% | +0.59% | |
| Form 6-K Enlivex Therapeutics For: Dec 04 | SEC filing · Form 6-K | +2.83% | +9.43% | |
| Form 6-K Enlivex Therapeutics For: Nov 26 | SEC filing · Form 6-K | -0.49% | -11.77% | |
| Form 6-K Enlivex Therapeutics For: Nov 24 | SEC filing · Form 6-K | -0.74% | -25.55% | |
| Form 6-K Enlivex Therapeutics For: Nov 18 | SEC filing · Form 6-K | +1.54% | +0.76% | |
| Form 6-K Enlivex Therapeutics For: Nov 14 | SEC filing · Form 6-K | +0.00% | +0.53% | |
| Form 6-K Enlivex Therapeutics For: Nov 10 | SEC filing · Form 6-K | +1.44% | +5.05% | |
| Form 6-K Enlivex Therapeutics For: Sep 25 | SEC filing · Form 6-K | -0.89% | +0.00% | |
| Form 6-K Enlivex Therapeutics For: Sep 11 | SEC filing · Form 6-K | +1.46% | +3.88% | |
| Form 6-K Enlivex Therapeutics For: Sep 09 | SEC filing · Form 6-K | +0.96% | -0.96% | |
| Form 6-K Enlivex Therapeutics For: Jun 30 | SEC filing · Form 6-K | -2.79% | +1.92% | |
| Form 6-K Enlivex Therapeutics For: Aug 18 | SEC filing · Form 6-K | -16.01% | -28.57% | |
| Form 6-K Enlivex Therapeutics For: Aug 14 | SEC filing · Form 6-K | +2.20% | +11.95% | |
| Form 6-K Enlivex Therapeutics For: Jul 28 | SEC filing · Form 6-K | +0.00% | +5.00% | |
| Form 6-K Enlivex Therapeutics For: May 30 | SEC filing · Form 6-K | +0.73% | -0.91% | |
| Form EFFECT Enlivex Therapeutics | SEC filing · Form EFFECT | — | -3.85% | |
| Form F-3 Enlivex Therapeutics | SEC filing · Form F-3 | +0.96% | +0.00% | |
| Form 20-F Enlivex Therapeutics For: Dec 31 | SEC filing · Form 20-F | +0.00% | +0.96% | |
| Form 6-K Enlivex Therapeutics For: Apr 23 | SEC filing · Form 6-K | +2.69% | +3.29% | |
| Form 6-K Enlivex Therapeutics For: Apr 21 | SEC filing · Form 6-K | +0.00% | +2.24% | |
| Form 6-K Enlivex Therapeutics For: Apr 03 | SEC filing · Form 6-K | +0.00% | -3.40% | |
| Form 6-K Enlivex Therapeutics For: Mar 31 | SEC filing · Form 6-K | +0.00% | -3.78% | |
| Form 6-K Enlivex Therapeutics For: Mar 17 | SEC filing · Form 6-K | -2.05% | -5.74% | |
| Form 6-K Enlivex Therapeutics For: Mar 04 | SEC filing · Form 6-K | +1.91% | +7.62% | |
| Form 6-K Enlivex Therapeutics For: Mar 03 | SEC filing · Form 6-K | -0.97% | -0.97% | |
| Form 6-K Enlivex Therapeutics For: Feb 18 | SEC filing · Form 6-K | -0.94% | -1.87% | |
| Form 6-K Enlivex Therapeutics For: Dec 11 | SEC filing · Form 6-K | +0.80% | +0.80% | |
| Form 6-K Enlivex Therapeutics For: Dec 03 | SEC filing · Form 6-K | -3.28% | +6.56% | |
| Form 6-K Enlivex Therapeutics For: Nov 29 | SEC filing · Form 6-K | -0.90% | -2.70% | |
| Form 6-K Enlivex Therapeutics For: Nov 20 | SEC filing · Form 6-K | +0.94% | -7.92% | |
| Form 6-K Enlivex Therapeutics For: Nov 14 | SEC filing · Form 6-K | +0.86% | -6.90% | |
| Form 6-K Enlivex Therapeutics For: Nov 12 | SEC filing · Form 6-K | +0.00% | -0.42% | |
| Form 6-K Enlivex Therapeutics For: Nov 08 | SEC filing · Form 6-K | -1.57% | -5.51% | |
| Form 6-K Enlivex Therapeutics For: Oct 31 | SEC filing · Form 6-K | +3.60% | +0.74% | |
| Form 6-K Enlivex Therapeutics For: Oct 30 | SEC filing · Form 6-K | -2.04% | -6.12% | |
| Form 6-K/A Enlivex Therapeutics For: Oct 14 | SEC filing · Form 6-K | +2.70% | +6.16% | |
| Form 6-K Enlivex Therapeutics For: Sep 26 | SEC filing · Form 6-K | +0.00% | +6.04% | |
| Form 6-K Enlivex Therapeutics For: Sep 24 | SEC filing · Form 6-K | +0.75% | -1.67% | |
| Form 6-K Enlivex Therapeutics For: Sep 11 | SEC filing · Form 6-K | +1.16% | +1.54% | |
| Form 6-K Enlivex Therapeutics For: Jun 30 | SEC filing · Form 6-K | +0.00% | +0.80% | |
| Form 6-K Enlivex Therapeutics For: Jul 23 | SEC filing · Form 6-K | -3.50% | +0.70% | |
| Form 6-K Enlivex Therapeutics For: Jun 24 | SEC filing · Form 6-K | +0.78% | +9.30% | |
| Form 6-K Enlivex Therapeutics For: Jun 20 | SEC filing · Form 6-K | +0.00% | -0.52% | |
| Form 6-K Enlivex Therapeutics For: Jun 17 | SEC filing · Form 6-K | +0.01% | -4.14% | |
| Form 6-K Enlivex Therapeutics For: Jun 14 | SEC filing · Form 6-K | +0.01% | -4.14% | |
| Form 6-K Enlivex Therapeutics For: Jun 03 | SEC filing · Form 6-K | -1.07% | +5.00% | |
| Form 6-K Enlivex Therapeutics For: May 29 | SEC filing · Form 6-K | +0.00% | +1.50% | |
| Form 6-K Enlivex Therapeutics For: May 28 | SEC filing · Form 6-K | +1.35% | -6.12% | |
| Form 20-F Enlivex Therapeutics For: Dec 31 | SEC filing · Form 20-F | -1.23% | -1.23% | |
| Form 6-K Enlivex Therapeutics For: Apr 29 | SEC filing · Form 6-K | +10.20% | +12.93% | |
| Form 6-K Enlivex Therapeutics For: Apr 22 | SEC filing · Form 6-K | +0.00% | +2.42% | |
| Form 6-K Enlivex Therapeutics For: Apr 16 | SEC filing · Form 6-K | +0.06% | +9.85% | |
| Form 6-K Enlivex Therapeutics For: Apr 11 | SEC filing · Form 6-K | -5.88% | -17.20% | |
| Form 6-K Enlivex Therapeutics For: Mar 29 | SEC filing · Form 6-K | +2.42% | +6.67% | |
| Form 6-K Enlivex Therapeutics For: Feb 07 | SEC filing · Form 6-K | +0.76% | +1.53% | |
| Form 6-K Enlivex Therapeutics For: Jan 22 | SEC filing · Form 6-K | +0.38% | +0.00% | |
| Form 6-K Enlivex Therapeutics For: Jan 17 | SEC filing · Form 6-K | -1.03% | -1.38% | |
| Form 6-K Enlivex Therapeutics For: Dec 20 | SEC filing · Form 6-K | +1.84% | +19.94% | |
| Form 6-K Enlivex Therapeutics For: Nov 09 | SEC filing · Form 6-K | +0.00% | +1.71% | |
| Form 6-K Enlivex Therapeutics For: Nov 07 | SEC filing · Form 6-K | +0.00% | -0.52% | |
| Form 6-K Enlivex Therapeutics For: Nov 02 | SEC filing · Form 6-K | +0.00% | +8.07% | |
| Form 6-K Enlivex Therapeutics For: Oct 26 | SEC filing · Form 6-K | +4.90% | +0.76% |
Keep exploring
More ENLV: earnings → · analyst actions → · ENLV overview →